Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Interferon Beta 1b for COVID-19
NCT04469491Phase 2Active, not recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Sep 2020
- Primary completion
- Jun 2023
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon beta-1b in coronavirus disease 2019 (COVID-19), sponsored by CHU Amiens-Picardie. Started Sep 2020; status: active, not recruiting.
02
Drugs
interferon beta-1b
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04469491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04469491.